Joel H Rubenstein MD MSc

Esophagus Disease

Director, Barrett's Esophagus Program and Professor, Division of Gastroenterology, University of Michigan and Research Scientist, Veterans Affairs Center for Clinical Management Research

Join to view full profile

1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000

Dr. Rubenstein is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rubenstein's full profile Already have an account?

Summary

Joel Rubenstein, MD is a Gastroenterologist based in Ann Arbor, MI, focusing on Esophagus Disease. His education includes a residency in Internal Medicine at the University of Chicago, a Fellowship in Gastroenterology at the University of Michigan Health System, and degrees from Washington University and University of Michigan. Dr. Rubenstein serves as the Director of the Barrett's Esophagus Program at University of Michigan Medical Center and as a Staff Physician at the Veterans Affairs Ann Arbor Healthcare System and a Research Scientist at VA Ann Arbor Healthcare System's Center for Clinical Management Research. He has numerous publications in major medical journals and is an active participant in related clinical studies. Dr. Rubenstein has been honored by several professional bodies, including the American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and American Gastroenterology Association.

Education & Training

University of Michigan School of Public HealthM.Sc., Clinical Research Design and Statistical Analysis, 2003 - 2005
University of MichiganFellowship, Gastroenterology, 2001 - 2004
University of ChicagoResidency, Internal Medicine, 1998 - 2001
WashU MedicineClass of 1998
University of Michigan College of Literature, Science, and ArtsB.S., Biophysics, Highest Distinction, 1990 - 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MI State Medical License 2002 - 2027
IL State Medical License 1998 - 2001
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2015
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015
Fellow American College of Gastroenterology, 2009

Clinical Trials

A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors Start of enrollment: 2012 Aug 13
COMPLETED
PHASE3

Publications & Presentations

PubMed

Shared decision making in Eosinophilic esophagitis: Integrating physician and patient perspectives.
Kerry A Ryan, Kelcie K Darpel, Joel H Rubenstein, Evan S Dellon, Lauren P Wallner
Plos One. 2026-01-01
1 citations
Validation of Tools Using the Electronic Health Record for Predicting Barrett's Esophagus With High-grade Dysplasia.
Joel H Rubenstein, Jennifer Burns, Maria E Arasim, Richard R Evans
Clinical Gastroenterology and Hepatology. 2026-01-01
9 citations
AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus.
Sachin Wani, Margaret J Zhou, Tarek Sawas, Joel H Rubenstein, Swathi Eluri
Gastroenterology. 2025-11-01

Journal Articles

National Trends in Use of Monitored Anesthesia Care for Outpatient Gastrointestinal Endoscopy in the Veterans Health Administration
Joel H Rubenstein, Jason A Dominitz, Sameer D Saini, JAMA
Helicobacter Pylori Infection Is Associated with Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium
Douglas A Corley, Nicholas J Shaheen, Joel H Rubenstein, Nature
Improving the Efficiency of Barrett's Esophagus Management: Do Biomarkers Hit the Mark? (Editorial)
Rubenstein JH, Gastrointestinal Endoscopy, 1/1/2014

Books/Book Chapters

Barrett's Esophagus and Esophageal Adenocarcinoma
Chapter: The Cost-effectiveness of Screening and Surveillance to Decrease Mortality from Esophageal Adenocarcinoma
Inadomi JM, Rubenstein JHEditors: Sharma P, Sampliner R.Blackwell Publishing, OxfordEdition 2nd,2006
Case-based Medicine Teaching Series Continuing Medical Education: Acid Related Disorders
Chapter: A Case of Refractory Heartburn
Rubenstein JH, Chey WDEditors: Howden CW.McMahon Publishing Group, New York2003

Abstracts/Posters

Implementation of a Brief Familial Cancer Assessment Tool Improves Surveillance Recommendations and Identification of Patients at Increased Risk for Colorectal Cancer
Guivatchian T, Koppe E, Foor-Pessin C, Chey WD, Eswaran S, Kolars J, Menees SB, Rajala M, Rice MD, Rizk R, Rubenstein JH, Sharma P, Todisco A, Stoffel EM, Gastroenterology, 1/1/2014
Malpractice Claims Alleging Failure to Screen for Esophageal Cancer: Commonplace or Boogeyman?
Adams MA, Rubenstein JH, Gastroenterology, 1/1/2014
A Survey of Expert Follow-up Practices After Successful Endoscopic Eradication Therapy for Complicated Barrett's Esophagus
Bedi AO, Kwon RS, Rubenstein JH, Piraka CR, Elta GH, Scheiman JM, Elmunzer BJ, DDW, Gastroenterology, 1/1/2013

Lectures

Epidemiologic Insights into the Etiology of Esophageal Adenocarcinoma
Division of Gastroenterology, University of Colorado Medical School, Denver, CO - 5/23/2014
Practical Solutions: Non-cardia Chest Pain
Plymouth, MI - 11/16/2013
Risk Stratification in Screening for Barrett's Esophagus
Chapel Hill, NC - 5/23/2013

Press Mentions

Barrett’s Esophagus: No Survival Difference Between Regular and at-Need SurveillanceMay 15th, 2025
AGA Issues Updated Guideline on Endoscopic Eradication Therapy for BEOctober 1st, 2024
Stay up to Date: Healio Recaps Pivotal Guidelines for GI, Liver Disease in 2024 (So Far)September 17th, 2024

Grant Support

Metabolome Risk Factors For Barrett'S EsophagusNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
The Epidemiology Of Adipokines In Barrett'S EsophagusNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Esophageal Sensation In Patients With HeartburnNational Center For Research Resources2004